Cadrenal Therapeutics, Inc.
CVKD • NASDAQ • Stock Fundamentals
Cadrenal Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Quang X. Pham, with a market cap of $12.4M.
Market Cap$12.4M
Employees4.0
CEOQuang X. Pham
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 10, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Cadrenal Therapeutics, Inc. FAQ
Common questions about Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc. (CVKD) has a market capitalization of $12.4M and trades on NASDAQ.
Cadrenal Therapeutics, Inc. has approximately 4 employees.